Inke S.A: APIs manufacturing plant.
01 1INKE SA
02 1Aurobindo Pharma Limited
03 1Cipla Ltd.
04 1Emcure Pharmaceuticals Limited
05 1Glenmark Life Sciences Limited
06 1Hetero Drugs Limited
07 1Jubilant Pharmova Limited
08 1MYLAN LABORATORIES LIMITED
09 2Natco Pharma Limited
10 1SMS Pharmaceuticals Limited
11 1Tianish Laboratories Private Limited
12 1Unichem Laboratories Limited, India
01 2RIZATRIPTAN BENZOATE
02 3Rizatriptan
03 7Rizatriptan Benzoate
04 1Rizatriptan benzoate
01 11India
02 1Spain
03 1U.S.A
Inke S.A: APIs manufacturing plant.
NDC Package Code : 64567-0013
Start Marketing Date : 2009-10-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-578
Start Marketing Date : 2024-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7580
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14593-872
Start Marketing Date : 2021-07-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (15kg/15kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0067
Start Marketing Date : 1998-06-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1147
Start Marketing Date : 2010-11-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63850-7138
Start Marketing Date : 2016-01-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63850-7119
Start Marketing Date : 2016-01-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53747-043
Start Marketing Date : 2014-03-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-653
Start Marketing Date : 2015-01-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A rizatriptan, benzoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of rizatriptan, benzoate, including repackagers and relabelers. The FDA regulates rizatriptan, benzoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. rizatriptan, benzoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of rizatriptan, benzoate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A rizatriptan, benzoate supplier is an individual or a company that provides rizatriptan, benzoate active pharmaceutical ingredient (API) or rizatriptan, benzoate finished formulations upon request. The rizatriptan, benzoate suppliers may include rizatriptan, benzoate API manufacturers, exporters, distributors and traders.
click here to find a list of rizatriptan, benzoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing rizatriptan, benzoate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for rizatriptan, benzoate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture rizatriptan, benzoate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain rizatriptan, benzoate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a rizatriptan, benzoate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of rizatriptan, benzoate suppliers with NDC on PharmaCompass.
We have 12 companies offering rizatriptan, benzoate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
